Vaccine Monitoring Platform: List of EMA-funded studies
Submitted by Anonymous (not verified) on 7 August 2025 - 12:45
Vaccine Monitoring Platform: List of EMA-funded studies
Medicine shortage communication (MSC): Zypadhera (olanzapine pamoate monohydrate powder and solvent for prolonged release suspension for injection)
Submitted by Anonymous (not verified) on 7 August 2025 - 10:12
Medicine shortage communication (MSC): Zypadhera (olanzapine pamoate monohydrate powder and solvent for prolonged release suspension for injection)
Agenda - Multi-stakeholder workshop on tailored clinical approach for biosimilars
Submitted by Anonymous (not verified) on 7 August 2025 - 10:08
Agenda - Multi-stakeholder workshop on tailored clinical approach for biosimilars
Ketoprofen: European public maximum-residue-limit assessment report (EPMAR) - CVMP
Submitted by Anonymous (not verified) on 6 August 2025 - 15:15
Ketoprofen: European public maximum-residue-limit assessment report (EPMAR) - CVMP
Quality guidelines
Submitted by Anonymous (not verified) on 6 August 2025 - 13:00
Quality guidelines
Feedback from European Medicine Agency (EMA) to the EU Commission request to evaluate the feasibility of alternatives to replace titanium dioxide (TiO2) in medicinal products and its possible impact on medicines’ availability
Submitted by Anonymous (not verified) on 6 August 2025 - 13:00
Feedback from European Medicine Agency (EMA) to the EU Commission request to evaluate the feasibility of alternatives to replace titanium dioxide (TiO2) in medicinal products and its possible impact on medicines’ availability
Clinical investigation of medicines for the treatment of Alzheimer's disease - Scientific guideline
Submitted by Anonymous (not verified) on 6 August 2025 - 12:00
Clinical investigation of medicines for the treatment of Alzheimer's disease - Scientific guideline
Concept paper on the need for revision of the guideline on the clinical investigation of medicines for the treatment of Alzheimer's disease
Submitted by Anonymous (not verified) on 6 August 2025 - 11:57
Concept paper on the need for revision of the guideline on the clinical investigation of medicines for the treatment of Alzheimer's disease
Opinion on medicine for use outside EU: Pyramax, artesunate,pyronaridine, Malaria, 16/02/2012 Positive opinion
Submitted by Anonymous (not verified) on 6 August 2025 - 11:15
Opinion on medicine for use outside EU: Pyramax, artesunate,pyronaridine, Malaria, 16/02/2012 Positive opinion
Marketing authorisation application (MAA) - pre-submission interactions form
Submitted by Anonymous (not verified) on 6 August 2025 - 10:20
Marketing authorisation application (MAA) - pre-submission interactions form